BioCity invests in early-stage precision medicine biotech

World |  News | 0 Comment | 29 Aug, 2019

BioCity, the pioneering life science incubator and business collective, on 29 August 2019, announced an investment in precision medicine biotech, Kinomica Ltd., via the Innovate UK Precisio...Read more

Crozet partners with PHV to develop Nipah virus vaccine

World |  News | 0 Comment | 28 Aug, 2019

Crozet BioPharma has announced a $10.8 million total value partnering agreement with Public Health Vaccines (PHV), to advance the development and manufacture of a vaccine against ...Read more

Harbour BioMed, PPD partner for oncology and immunology

World |  News | 0 Comment | 28 Aug, 2019

Harbour BioMed (HBM), a global clinical-stage biopharmaceutical company, and Pharmaceutical Product Development, LLC (PPD), a leading global contract research organization (CRO), ...Read more

FDA fast tracks AstraZeneca's FARXIGA

World |  News | 0 Comment | 28 Aug, 2019

AstraZeneca has announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of FARXIGA (dapagliflozin) to delay the progression of renal ...Read more

Global Neurorehabilitation devices market to be worth $3.2B by 2024

World |  News | 0 Comment | 28 Aug, 2019

The global Neurorehabilitation Devices Market is foreseen to project a notable growth because of the rising prevalence of neurological illnesses. Rising cases of neurological diso...Read more

FDA approves new add-on drug to treat Parkinson's disease

World |  News | 0 Comment | 28 Aug, 2019

The U.S. Food and Drug Administration, on 27 August 2019, approved Nourianz (istradefylline) tablets as an add-on treatment to levodopa/carbidopa in adult patients with Parkinson's disease ...Read more

KPMG, Thermo Fisher to work on gene interaction with medicines

World |  News | 0 Comment | 28 Aug, 2019

KPMG's Clinical Intelligence (KCI) platform is helping clinicians improve the quality of care by furnishing them with pharmacogenomics data – information about how genes interact with...Read more

Studies shows critically ill patients use Masimo ORi to reduce hyperoxia

World |  News | 0 Comment | 27 Aug, 2019

Masimo, on 27 August 2019, announced the latest publication of a report on 150 randomized controlled trials of ICU patients in Intensive Care Medicine. Researchers evaluated with pure ...Read more

Agilent Completes Acquisition of BioTek Instruments

World |  News | 0 Comment | 27 Aug, 2019

Agilent Technologies has announced it has completed the acquisition of BioTek Instruments, a global leader in the design, manufacture and distribution of innovative life science instrumenta...Read more

GE's Drawbridge Health Receives FDA nod for blood testing system

World |  News | 0 Comment | 27 Aug, 2019

Drawbridge Health, Founded in 2015 by GE Ventures and GE Healthcare, Drawbridge Health is a healthcare technology company  has announced that it has received 510(k) clearance...Read more

Amgen buys Celgene's OTEZLA for $13.4 Bn

World |  News | 0 Comment | 27 Aug, 2019

Bristol-Myers Squibb Company has announced that Celgene Corporation  in connection with its merger agreement with Bristol-Myers Squibb, has entered into an agreement with Amgen  u...Read more

Gilead, Galapagos close their development collaboration

World |  News | 0 Comment | 26 Aug, 2019

Gilead Sciences and Galapagos have announced the closing of the global research and development collaboration agreement signed on July 14, 2019. This agreement has received clearance from ...Read more

Myomo announces technology licensing program for international markets

World |  News | 0 Comment | 26 Aug, 2019

Myomo, Inc. is a wearable medical robot company that provides greater mobility for people with neurological disorders and upper extremity paralysis. The company, on 23 August 2019, announce...Read more

New trial to evaluate an investigational drug for Parkinson's disease

World |  News | 0 Comment | 26 Aug, 2019

Suncoast Neuroscience Associates is recruiting for a clinical research study to evaluate an investigational medication in people diagnosed with Parkinson's disease who are experiencing symp...Read more

Merck, Thermis collaborate to develop vaccines

World |  News | 0 Comment | 23 Aug, 2019

Themis Bioscience has announced a research collaboration and exclusive license agreement with MSD (tradename of Merck & Co., Inc., Kenilworth, N.J., USA) for the discovery and...Read more

The Asia Pacific cardiovascular devices market to reach $16,107.3 Mn in 2027

World |  News | 0 Comment | 23 Aug, 2019

The "Asia Pacific Cardiovascular Devices Market to 2027 - Regional Analysis and Forecasts By Device, Pacemaker, Stent, Defibrillator, Cardiac Catheter, Guidewire, Heart Valve, Event Mo...Read more

Rexgenero receives £267,000 innovate UK grant for Cell therapy stabilization technologies

World |  News | 0 Comment | 22 Aug, 2019

Rexgenero, a regenerative medicine company based in Spain pioneering the development of advanced cell-based therapies to treat chronic limb-threatening ischaemia (CLI), welcomes the news an...Read more

Miracor Medical Granted FDA Breakthrough Device Designation for the PiCSO Impulse System

World |  News | 0 Comment | 22 Aug, 2019

Belgium based Miracor Medical SA (Miracor Medical) has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its PiCSO® Impulse System for...Read more